Intech Biopharm Corporation (TPEX:6461)
Taiwan · Delayed Price · Currency is TWD 16.00
+0.05 (0.31%)
Nov 6, 2025, 10:33 AM CST
Intech Biopharm Market Cap
Intech Biopharm has a market cap or net worth of 2.6 billion as of November 5, 2025. Its market cap has decreased by -35.78% in one year.
Market Cap
2.60B
Enterprise Value
3.57B
Revenue
115.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
16.00
Market Cap Chart
Since July 15, 2014, Intech Biopharm's market cap has decreased from 4.00B to 2.60B, a decrease of -35.11%. That is a compound annual growth rate of -3.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 2.63B | -27.75% |
| Dec 31, 2024 | 3.64B | -11.36% |
| Dec 29, 2023 | 4.11B | 5.65% |
| Dec 30, 2022 | 3.89B | 67.22% |
| Dec 30, 2021 | 2.33B | 11.52% |
| Dec 31, 2020 | 2.09B | 40.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 228.00B |
| PharmaEssentia | 184.18B |
| Bora Pharmaceuticals Co., LTD. | 76.08B |
| Lotus Pharmaceutical | 75.61B |
| Lumosa Therapeutics | 35.63B |
| Oneness Biotech | 31.37B |
| Pegavision | 27.22B |
| Center Laboratories | 26.35B |